UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Conversation With Dr Janet Eary of the NCI Cancer Imaging Program on Federal Priorities in Cancer Imaging

American journal of roentgenology (1976), 2024-05

Eary, Janet F.

2024

Volltextzugriff (PDF)

Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease

Journal of Nuclear Medicine, 2014-07, Vol.55 (7), p.1106-1111

2014

Volltextzugriff (PDF)

Do we need Quantitative Imaging?

Nuklearmedizin. Nuclear medicine, 2020-06, Vol.59 (3), p.225

2020

Volltextzugriff (PDF)

Radionuclide, magnetic resonance and computed tomography imaging in European round back slugs (Arionidae) and leopard slugs (Limacidae)

Scientific reports, 2021-07, Vol.11 (1), p.1-8, Article 13798

2021

Volltextzugriff (PDF)

Cancer Imaging Program Update: 2020

Radiology. Imaging cancer, 2020-07, Vol.2 (4), p.e204021-e204021

Eary, Janet F

2020

Volltextzugriff (PDF)

Clarification of Concerns about the Demographic Composition of The Cancer Imaging Archive

Radiology. Imaging cancer, 2024-05, Vol.6 (3), p.e240098

2024

Volltextzugriff (PDF)

Proton MR Spectroscopy Measurements of White and Brown Adipose Tissue in Healthy Humans: Relaxation Parameters and Unsaturated Fatty Acids

Radiology, 2021-05, Vol.299 (2), p.396-406

2021

Volltextzugriff (PDF)

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Radiology, 2020-09, Vol.296 (3), p.564-572

2020

Volltextzugriff (PDF)

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study

Drug metabolism and disposition, 2015-11, Vol.43 (11), p.1795-1804

2015

Volltextzugriff (PDF)

Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome

Journal of bone and joint surgery. American volume, 2014-01, Vol.96 (2), p.152-158

2014

Volltextzugriff (PDF)

[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8828-8834

2005

Volltextzugriff (PDF)

NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

Cancer, 2012-09, Vol.118 (18), p.4564-4570

2012

Volltextzugriff (PDF)

Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond

Clinical cancer research, 2007-06, Vol.13 (12), p.3460-3469

2007

Volltextzugriff (PDF)

Imaging in sarcoma

Journal of Nuclear Medicine, 2011-12, Vol.52 (12), p.1903-1913

2011

Volltextzugriff (PDF)

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab

Molecular imaging, 2019-01, Vol.18, p.1536012119829986-1536012119829986

2019

Volltextzugriff (PDF)

Sport Concussion Assessment Tool – 2: Baseline Values for High School Athletes

British journal of sports medicine, 2012-04, Vol.46 (5), p.365-370

2012

Volltextzugriff (PDF)

Spatially coherent modeling of 3D FDG-PET data for assessment of intratumoral heterogeneity and uptake gradients

Journal of medical imaging (Bellingham, Wash.), 2022-07, Vol.9 (4), p.045003-045003

2022

Volltextzugriff (PDF)

Supporting Imaging at the Highest Level: Janet Eary Talks with Lale Kostakoglu About NCI Leadership in Advancing Imaging

Journal of Nuclear Medicine, 2024-05, Vol.65 (5), p.667-669

2024

Volltextzugriff (PDF)

[F‐18]‐fluorodeoxy‐D‐glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

Cancer, 2009-08, Vol.115 (15), p.3519-3525

2009

Volltextzugriff (PDF)

A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)

Molecular imaging and biology, 2014-06, Vol.16 (3), p.431-440

2014

Volltextzugriff (PDF)

Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy

The Journal of nuclear medicine (1978), 2022-08, Vol.63 (8), p.1184-1190

2022

Volltextzugriff (PDF)

Predictors of 18 F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy

Journal of Nuclear Medicine, 2022-08, Vol.63 (8), p.1184-1190

2022

Volltextzugriff (PDF)

Molecular Targeting of Platelet-Derived Growth Factor B by Imatinib Mesylate in a Patient With Metastatic Dermatofibrosarcoma Protuberans

Journal of clinical oncology, 2002-09, Vol.20 (17), p.3586-3591

2002

Volltextzugriff (PDF)

18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy

The Journal of nuclear medicine (1978), 2020-06, Vol.61 (6), p.881-889

2020

Volltextzugriff (PDF)

Noninvasive imaging of experimental lung fibrosis

American journal of respiratory cell and molecular biology, 2015-07, Vol.53 (1), p.8-13

2015

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Englisch
(222)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(119)
Science & Technology
(111)
Life Sciences & Biomedicine
(107)
Biological And Medical Sciences
(63)
Medical Sciences
(62)
Male
(61)
Radiology, Nuclear Medicine & Medical Imaging
(57)
Middle Aged
(56)
Female
(54)
Adult
(45)
Oncology
(34)
Aged
(33)
Tumors
(28)
Fluorodeoxyglucose F18
(27)
Animals
(24)
Radiopharmaceuticals
(22)
Tomography, Emission-Computed
(21)
Investigative Techniques, Diagnostic Techniques
(19)
Positron Emission Tomography
(19)
Tissue Distribution
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Conversation With Dr Janet Eary of the NCI Cancer Imaging Program on Federal Priorities in Cancer Imaging

Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease

Do we need Quantitative Imaging?

Radionuclide, magnetic resonance and computed tomography imaging in European round back slugs (Arionidae) and leopard slugs (Limacidae)

Cancer Imaging Program Update: 2020

Clarification of Concerns about the Demographic Composition of The Cancer Imaging Archive

Proton MR Spectroscopy Measurements of White and Brown Adipose Tissue in Healthy Humans: Relaxation Parameters and Unsaturated Fatty Acids

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study

Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome

[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors

NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond

Imaging in sarcoma

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab

Sport Concussion Assessment Tool – 2: Baseline Values for High School Athletes

Spatially coherent modeling of 3D FDG-PET data for assessment of intratumoral heterogeneity and uptake gradients

Supporting Imaging at the Highest Level: Janet Eary Talks with Lale Kostakoglu About NCI Leadership in Advancing Imaging

[F‐18]‐fluorodeoxy‐D‐glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)

Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy

Predictors of 18 F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy

Molecular Targeting of Platelet-Derived Growth Factor B by Imatinib Mesylate in a Patient With Metastatic Dermatofibrosarcoma Protuberans

18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy

Noninvasive imaging of experimental lung fibrosis

Suchergebnisse filtern